US EditionLatest trial results offer promise of sustained treatment for the heart’s “forgotten valve” - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Latest trial results offer promise of sustained treatment for the heart’s “forgotten valve” - Cardiovascular News
Two-year results of the TRILUMINATE pivotal trial demonstrate a sustained benefit of tricuspid transcatheter edge-to-edge repair (T-TEER) for the treatment of severe tricuspid regurgitation “We’ve referred to this as the forgotten valve,” Gagan Singh (UC Davis Health, Sacramento, USA), an investigator in the trial, tells Cardiovascular News, referencing the fact that solutions for the treatment of tricuspid valve disease have often lagged behind…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
